1. Home
  2. FXHO vs ICCC Comparison

FXHO vs ICCC Comparison

Compare FXHO & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FXHO

UTime Limited Class A Ordinary Shares

BUY

Current Price

$6.60

Market Cap

83.2M

Sector

N/A

ML Signal

BUY

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.39

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXHO
ICCC
Founded
2008
1982
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.2M
93.1M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
FXHO
ICCC
Price
$6.60
$10.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 32.4K
7.5K
Earning Date
08-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.41
Revenue
N/A
★ $26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$25.80
Revenue Growth
N/A
★ 51.64
52 Week Low
$7.67
$4.52
52 Week High
$25.00
$12.10

Technical Indicators

Market Signals
Indicator
FXHO
ICCC
Relative Strength Index (RSI) 29.98 51.84
Support Level N/A $9.45
Resistance Level $13.80 $10.82
Average True Range (ATR) 1.14 0.23
MACD -0.29 0.05
Stochastic Oscillator 0.46 51.36

Price Performance

Historical Comparison
FXHO
ICCC

About FXHO UTime Limited Class A Ordinary Shares

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: